ERBB2 and neoplasm: Induced overexpression of biglycan in HER‐2/neu cells increases MHC class I expression and decreases miR‐21‐3p, highlighting the vital role of biglycan in the MHC class I‐driven immune escape in tumor cells (211) (Figure 2).